CLPT - Company ID 0001285550
The table below shows ClearPoint Neuro, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $12.13M | $8.86M | $9.21M | $8.48M | $8.12M | $7.86M |
| Cost of revenue | $4.37M | $3.26M | $3.66M | $3.35M | $3.27M | $2.87M |
| Gross profit | $7.76M | $5.60M | $5.56M | $5.13M | $4.85M | $4.99M |
| R&D | $4.52M | $3.45M | $3.83M | $3.38M | $3.31M | $3.12M |
ClearPoint Neuro, Inc. reported annual revenue of $36.97M for fiscal year 2025. That is up 17.8% from $31.39M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $5.75M (FY 2016) to $36.97M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $5.00M | $3.59M | $3.39M | $4.08M | $3.14M | $2.76M |
| Operating income | -$8.48M | -$5.28M | -$5.68M | -$6.16M | -$5.16M | -$4.72M |
| Income tax | $8.00K | $8.00K | $25.00K | $18.00K | $14.00K | $15.00K |
| Net income | -$9.55M | -$5.89M | -$5.84M | -$6.03M | -$4.97M | -$4.41M |
| EPS (diluted) | -$0.32 | -$0.21 | -$0.21 | -$0.22 | -$0.18 | -$0.16 |